The Parkinson Progression Marker Initiative (PPMI)

Overview of attention for article published in Progress in Neurobiology, September 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
patent: 4 patents

wikipedia: 1 Wikipedia page
guideline: 2 clinical guideline sources

Readers on

mendeley: 723 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 2 Guidelines that reference this research output.

Guide de rédaction des protocoles d’examens d’imagerie de la neurotransmission pour l’exploration des mouvements anormaux

Clinical guideline published by Société Française de Médecine Nucléaire et Imagerie Moléculaire (SFMN) on 01 Mar 2021

The Société Française de Médecine Nucléaire et Imagerie Moléculaire (SFMN) is dedicated to advancing nuclear medicine and molecular imaging in France. It provides resources, guidelines, and organizes events to enhance professional practice and knowledge in the field.

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

Clinical guideline published by European Association of Nuclear Medicine (EANM) on 09 May 2020

The European Association of Nuclear Medicine (EANM) is a leading non-profit organization dedicated to advancing nuclear medicine in Europe. Established in 1985, it fosters collaboration among professionals, promotes education, and provides clinical guidelines to enhance patient care and public health.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.